ERBB2 and breast carcinoma: Breast cancer subtypes were defined as luminal (ER+ and/or PR+), HER2-enriched (ER-, PR-, HER2+), and triple negative (TNBC) (ER-, PR-, HER-) and their association with OR51J1 expression were evaluated and no significant correlation was observed (P = 0.059).